Vimarsana
Biggest News Aggregation in the World

Page 25 - Research Evaluation News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Research Evaluation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Research Evaluation Today - Breaking & Trending Today

State agency questions procurement process in energy transition funding requests - Vimarsana News

State agency questions procurement process in energy transition funding requests

Questions about the request for proposals process have delayed the allocation of energy transition funds to projects selected by a state agency, Indian Affairs Department Secretary Designee James Mountain said during an Indian Affairs Committee meeting on Tuesday. Mountain said it is prudent and his responsibility to check and see if the process was done […]

Cancer Council Victoria's 'Don't take the risk, take the test' via Bastion - Vimarsana News

Cancer Council Victoria's 'Don't take the risk, take the test' via Bastion

Featuring Bastion CD Laurie Cronin and his own personal story.

8 projects awarded KYNETIC commercialization grants - Vimarsana News

8 projects awarded KYNETIC commercialization grants

The program offers entrepreneurial education and proof-of-concept/product development grants to accelerate the translation of academic innovations into biomedical products by investigators throughout the Commonwealth of Kentucky.

Source: uky.edu
ICTlogy » ICT4D Bibliography » Work » Research Evaluation - Vimarsana News

ICTlogy » ICT4D Bibliography » Work » Research Evaluation

Research on the Information Society, the Digital Divide and Information and Communication Technologies for development

Cytokinetics Announces Start of MAPLE-HCM, a Phase 3 Clinical Trial of Aficamten Compared to Metoprolol in Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy - Vimarsana News

Cytokinetics Announces Start of MAPLE-HCM, a Phase 3 Clinical Trial of Aficamten Compared to Metoprolol in Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy

First Phase 3 Trial Evaluating Monotherapy with a Cardiac Myosin Inhibitor Compared to Monotherapy with a Beta Blocker in Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy SOUTH SAN... | June 20, 2023